Oculis Holding AG
OCS-01
diabetic macular edema
Resolved
7days ago
Phase 3 readout · Jun 30, 2026
What's at stake
Phase 3 trial results for OCS-01 in diabetic macular edema are due Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 12h ago
“the topline results from both DIAMOND Phase 3 trials are expected in June 2026,”